Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2011-03-15
2011-03-15
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S009100, C514S002600, C514S012200, C530S350000
Reexamination Certificate
active
07906124
ABSTRACT:
Treatment and procedures for treating bodily conduits involves deactivating, killing, or otherwise treating smooth muscle tissue of the conduit.
REFERENCES:
patent: 5437291 (1995-08-01), Pasricha et al.
patent: 5728094 (1998-03-01), Edwards
patent: 5766605 (1998-06-01), Sanders et al.
patent: 5972026 (1999-10-01), Laufer et al.
patent: 5976175 (1999-11-01), Hirano et al.
patent: 6003517 (1999-12-01), Sheffield et al.
patent: 6045549 (2000-04-01), Smethers et al.
patent: 6083255 (2000-07-01), Laufer et al.
patent: 6200333 (2001-03-01), Laufer
patent: 6273907 (2001-08-01), Laufer
patent: 6283988 (2001-09-01), Laufer et al.
patent: 6283989 (2001-09-01), Laufer et al.
patent: 6299633 (2001-10-01), Laufer
patent: 6411852 (2002-06-01), Danek et al.
patent: 6488673 (2002-12-01), Laufer et al.
patent: 6493589 (2002-12-01), Medhkour et al.
patent: 6634363 (2003-10-01), Danek et al.
patent: 6743197 (2004-06-01), Edwards
patent: 6767544 (2004-07-01), Brooks et al.
patent: 6770070 (2004-08-01), Balbierz
patent: 6840243 (2005-01-01), Deem et al.
patent: 6974579 (2005-12-01), Brin et al.
patent: 7027869 (2006-04-01), Danek et al.
patent: 7264002 (2007-09-01), Danek et al.
patent: 7273055 (2007-09-01), Danek et al.
patent: 7542802 (2009-06-01), Danek et al.
patent: 7556624 (2009-07-01), Laufer et al.
patent: 7740017 (2010-06-01), Danek et al.
patent: 2004/0009180 (2004-01-01), Donovan
patent: 2004/0013692 (2004-01-01), Aoki et al.
patent: 2005/0010270 (2005-01-01), Laufer
patent: 2006/0062808 (2006-03-01), Laufer et al.
patent: 2006/0137698 (2006-06-01), Danek et al.
patent: 2006/0254600 (2006-11-01), Danek et al.
patent: 2006/0278243 (2006-12-01), Danek et al.
patent: 2006/0278244 (2006-12-01), Danek et al.
patent: 2007/0083197 (2007-04-01), Danek et al.
patent: 2007/0102011 (2007-05-01), Danek et al.
patent: 2007/0106296 (2007-05-01), Laufer et al.
patent: 2007/0106348 (2007-05-01), Laufer
patent: 2007/0118190 (2007-05-01), Danek et al.
patent: 2008/0004596 (2008-01-01), Yun et al.
patent: 2009/0112203 (2009-04-01), Danek et al.
patent: 2009/0143705 (2009-06-01), Danek et al.
patent: 2009/0143776 (2009-06-01), Danek et al.
patent: 2009/0192508 (2009-07-01), Laufer et al.
patent: WO-9505842 (1995-03-01), None
patent: WO0062699 (2000-10-01), None
An, S.S et al., Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma, European Respiratory Journal, 2007, vol. 29, No. 5, pp. 834-800.
Bel, E. H., Hot Stuff: Bronchial Thermoplasty for Asthma, American Journal of Respiratory and Critical Care Medicine, 2006, vol. 173, pp. 941-942.
Brown, R. H. et al., In vivo evaluation of the effectiveness of bronchial thermoplasty with computed tomography, Journal of Applied Physiology, 2005, vol. 98, pp. 1603-1606.
Brown, R. H. et al., Effect of bronchial thermoplasty on airway distensibility, European Respiratory Journal, vol. 26, No. 2, pp. 277-282.
Chhajed, P., Will There be a Role for Bronchoscopic Radiofrequency Ablation?, 2005, J Bronchol, vol. 12, No. 3, p. 184.
Cox, G., et al., Early Clinical Experience With Bronchial Thermoplasty for the Treatment of Asthma, 2002, p. 1068.
Cox, G. et al., Asthma Control During the Year After Bronchial Thermoplasty, The New England Journal of Medicine, Mar. 29, 2007, vol. 356, No. 13, pp. 21327-1337.
Cox, G. et al., Bronchial Thermoplasty: One-Year Update, American Thoracic Society Annual Meeting, 2004, p. 1.
Cox, G., et al., Development of a Novel Bronchoscopic Therapy for Asthma, Journal of Allergy and Clinical Immunology, 2003, p. 1.
Cox, G., et al., Bronchial Thermoplasty for Asthma, American Journal of Respiratory and Critical Care Medicine, 2006, vol. 173, pp. 965-969.
Cox, G., et al., Bronchial Thermoplasty: Long-Term Follow-up and Patient Satisfaction, 2004, p. 1.
Cox, G., et al., Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations, European Respiratory Journal, 2004, 24, pp. 659-663.
Cox, G., et al., Clinical Experience with Bronchial Thermoplasty for the Treatment of Asthma, 2003, Chest 124, p. 106S.
Cox, G., et al., Impact of bronchial thermoplasty on asthma status: interim results from the AIR trial, 2006. European Respiratory Society Annual Meeting. Munich, Germany, p. 1.
Danek, C. J., et al., Bronchial thermoplasty reduces canine airway responsiveness to local methacholine challenge, 2002, American Thoracic Society Annual Meeting, p. 1.
Danek, C. J., et al., Asthma Intervention Research (AIR) Trial Evaluating Bronchial Thermoplasty™: Early Results, 2002, American Thoracic Society Annual Meeting, p. 1.
Danek, C.J., et al., Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs, J. Appl Physiol, 2004, vol. 97, pp. 1946-1953.
Solway, J. at al., Airway Smooth Muscle as a Target for Asthma Therapy, The New England Journal of Medicine, Mar. 29, 2007, 356(13), pp. 1367-1369.
Laviolette, et al., Asthma Intervention Research (AIR) Trial: Early Safety Assessment of Bronchial Thermoplasty, 2004, p. 1.
Leff, et al., Bronchial Thermoplasty Alters Airway Smooth Muscle and Reduces Responsiveness in Responsiveness in Dogs: A Possible Procedure for the Treatment of Asthma, American Thoracic Society Annual Meeting, 2002, p. 1.
Lim, E. C. et al., Botulinum Toxin: A Novel Therapeutic Option for Bronchial Asthma?, Medical Hypotheses, 2006, vol. 66, pp. 915-919.
Lombard, et al., Histologic Effects of Bronchial Thermoplasty of Canine and Human Airways, American Thoracic Society Annual Meeting, 2002, p. 1.
Mayse, M. et al., Clinical Pearls for Bronchial Thermoplasty, J Bronchol, Apr. 2007, vol. 14, No. 2, pp. 115-123.
Miller, J. D. et al., A Prospective Feasibility Study of Bronchial Thermoplasty in the Human Airway, 2005, vol. 127, No. 6, pp. 1999-2006.
Miller, J. D. et al., Bronchial Thermoplasty is Well Tolerated by Non-Asthmatic Patients Requiring Lobectomy, 2002, American Thoracic Society Annual Meeting, p. 1.
Rubin, et al. Bronchial Thermoplasty Improves Asthma Status of Moderate to Severe Peristent Asthmatics Over and Above Current Standard-of-Care, 2006, American College of Chest Physicians, 2 pages.
Wilson, S. R. et al., Global assessment after bronchial thermoplasty: the patient's perspective, Journal of Outcomes Research, 2006, vol. 10, pp. 37-46.
Sterk, P. J., Heterogencity of Airway Hyperresponsiveness: Time for Unconventional, but Traditional Studies, 2004, The American Pshychological Society, pp. 2017-2018.
Toma, T. P., Brave New World for Interventional Bronchoscopy, 2005, Thorax, vol. 60, pp. 180-181.
Trow, T., Clinical Year in Review 1, proceedings of the American Thoracic Society, 2006, vol. 3, pp. 553-556.
Wizeman, et al., A Computer Model of Thermal Treatment of Airways by Radiofrequency (RF) Energy Delivery, 2007, American Thoracic Society Annual Meeting, p. 1.
Bakhai, et al., “Bronchial Artery Delivery Of Viral Vectors For Gene Delivery In Cystic Fibrosis; Superior To Airway Delivery?,”BMC Pulmonary Medicine, Apr. 3, 2002, pp. 1-4, 2:2, available from http://www.biomedcentral.com/1471-2466/2/2.
Google search, Botox, Juvederm, Restylane, Artefill in Dallas. 2 pages, http://www.google.com/search?sourceid=navclient&aq=t&le=UTF-8&ris=GWYA,GWYA:2005-07,GWYA:en&q=botox+microsphere+size (Oct. 11, 2007).
Scheving, et al., “Microsphere Drug Delivery Systems,”Chronobiotechnology and Chronobiological Engineering, 1987, pp. 56-58, ISBN 90-247-3471-1, Martinus Nijhoff Publishers.
Spencer, James M., “Chapter 2: Facial Anatomy and the Use of Botulinum Toxin,”Botulinum Toxin in Clinical Dermatology, 2006, pp. 43-44, ISBN 1-842-14-2445, Taylor & Francis.
Campbell et al., 1999. Biology, Fifth Edition. ISBN 0-8053-6573-7, Benjamin/Cummings. Chapter 42, p. 822-823.
Davis, L.E., 1993. Botulinum Toxin From Poison to Medicine. West J Med., 158:25-29.
Raven, P.H. and Johnson G.B., 1992. Biology, Third Edition. ISBN 0-8016-6372-5, Mosby-Year Book, Inc. Chapter 51, p. 1060 and 1062-1063.
National Institute of Allergy and Infectious Diseases. Summary of the NIAID Expert Panel on Botulinum
Auth David C.
Danek Christopher J.
Kaplan Gary S.
Laufer Michael D.
Wizeman William J.
Asthmatx, Inc.
Kam Chih-Min
Perkins Coie LLP
LandOfFree
Inactivation of smooth muscle tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inactivation of smooth muscle tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactivation of smooth muscle tissue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2746857